Menu
← Oncology Approval Tracker
FDA DECISION ·
Tivdak
tisotumab vedotin-tftv · Seagen (Pfizer)
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with recurrent or metastatic cervical cancer that progressed on or after chemotherapy.
LAMPGEN ANALYSIS
Why it matters
The randomized innovaTV 301 results supported traditional approval of the tissue factor-directed antibody–drug conjugate.
What research teams should watch
Build eye exams and ocular precautions into each relevant visit and document bleeding and neuropathy assessments consistently.
PRIMARY RECORDS